Artigo Revisado por pares

THE RELATIONSHIP BETWEEN THE METABOLISM OF RIBAVIRIN AND ITS PROPOSED MECHANISM OF ACTION

1977; Wiley; Volume: 284; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1977.tb21953.x

ISSN

1749-6632

Autores

Jon P. Miller, Linda J Kigwana, David Streeter, Roland K. Robins, Lionel N. Simon, John Roboz,

Tópico(s)

HIV/AIDS drug development and treatment

Resumo

Annals of the New York Academy of SciencesVolume 284, Issue 1 p. 211-229 THE RELATIONSHIP BETWEEN THE METABOLISM OF RIBAVIRIN AND ITS PROPOSED MECHANISM OF ACTION Jon P. Miller, Jon P. Miller Nucleic Acid Research Institute ICN Pharmaceuticals, Inc. Irvine, California 92714 Stanford Research Institute-Washington, 1611 N. Kent Street, Arlington, Virginia 22209.Search for more papers by this authorLinda J Kigwana, Linda J Kigwana Nucleic Acid Research Institute ICN Pharmaceuticals, Inc. Irvine, California 92714 Advanced Therapeutics Program, LAC/USC Cancer Center, Los Angeles, California 90033Search for more papers by this authorDavid G Streeter, David G Streeter Nucleic Acid Research Institute ICN Pharmaceuticals, Inc. Irvine, California 92714 Newport Pharmaceuticals International, Inc., Newport Beach, California 92660.Search for more papers by this authorRoland K Robins, Roland K Robins Nucleic Acid Research Institute ICN Pharmaceuticals, Inc. Irvine, California 92714Search for more papers by this authorLionel N Simon, Lionel N Simon Nucleic Acid Research Institute ICN Pharmaceuticals, Inc. Irvine, California 92714 Newport Pharmaceuticals International, Inc., Newport Beach, California 92660.Search for more papers by this authorJohn Roboz, John Roboz Nucleic Acid Research Institute ICN Pharmaceuticals, Inc. Irvine, California 92714Search for more papers by this author Jon P. Miller, Jon P. Miller Nucleic Acid Research Institute ICN Pharmaceuticals, Inc. Irvine, California 92714 Stanford Research Institute-Washington, 1611 N. Kent Street, Arlington, Virginia 22209.Search for more papers by this authorLinda J Kigwana, Linda J Kigwana Nucleic Acid Research Institute ICN Pharmaceuticals, Inc. Irvine, California 92714 Advanced Therapeutics Program, LAC/USC Cancer Center, Los Angeles, California 90033Search for more papers by this authorDavid G Streeter, David G Streeter Nucleic Acid Research Institute ICN Pharmaceuticals, Inc. Irvine, California 92714 Newport Pharmaceuticals International, Inc., Newport Beach, California 92660.Search for more papers by this authorRoland K Robins, Roland K Robins Nucleic Acid Research Institute ICN Pharmaceuticals, Inc. Irvine, California 92714Search for more papers by this authorLionel N Simon, Lionel N Simon Nucleic Acid Research Institute ICN Pharmaceuticals, Inc. Irvine, California 92714 Newport Pharmaceuticals International, Inc., Newport Beach, California 92660.Search for more papers by this authorJohn Roboz, John Roboz Nucleic Acid Research Institute ICN Pharmaceuticals, Inc. Irvine, California 92714Search for more papers by this author First published: May 1977 https://doi.org/10.1111/j.1749-6632.1977.tb21953.xCitations: 70 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume284, Issue1Third Conference on Antiviral SubstancesMay 1977Pages 211-229 RelatedInformation

Referência(s)